CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to MZL
Related studies linked through entity extraction aliases.
Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Indolent Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL)
- Status
- COMPLETED
- Phase
- PHASE2